Thelaziasis in humans: A systematic review of reported cases
Abstract
Background: Thelaziasis is an emerging vector-borne zoonotic disease caused by Thelazia spp., which primarily affects animals but is increasingly recognised in humans, where it causes ocular infections. Human thelaziasis remains underreported and poorly understood in many regions despite its growing relevance.
Methods: This systematic review analyzed epidemiological, clinical, diagnostic, and therapeutic data from 134 documented human cases of thelaziasis reported across 18 countries. Data sources included peer-reviewed publications and case reports, focusing on identifying trends in geographic distribution, clinical presentation, diagnostic techniques, and treatment approaches.
Results: Most cases (82.8%) were reported in Asia, particularly in South Korea, China, India, and Japan. The most common symptoms were foreign body sensation (53%), conjunctival hyperemia (39.6%), and epiphora (33.6%). Infestation was unilateral in 90.3% of cases. Diagnosis was primarily made through direct visual identification of the parasite, while molecular confirmation was used in a limited number of cases. Thelazia callipaeda was the predominant species identified (88.8%). Manual extraction was the mainstay of treatment (88.8%), with antiparasitic agents used in selected instances. Reinfection occurred in 6% of cases.
Conclusion: This review underscores the growing recognition of human thelaziasis, particularly in Asia, and highlights the potential underdiagnosis in non-endemic regions.…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.